Redirect Notice

Looks like you clickedhttps://www.boehringer-ingelheim.com/press-release/pradaxa-dabigatran-etexilate-150mg-bid-continues-be-only-oral-anticoagulant-which

If you do not want to visit that page, you can close this browser tab.